0001209191-17-067417.txt : 20171227 0001209191-17-067417.hdr.sgml : 20171227 20171227164809 ACCESSION NUMBER: 0001209191-17-067417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171227 FILED AS OF DATE: 20171227 DATE AS OF CHANGE: 20171227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandercock Colin CENTRAL INDEX KEY: 0001724870 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 171276484 MAIL ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-27 0 0001645460 Cue Biopharma, Inc. CUE 0001724870 Sandercock Colin 675 W. KENDALL STREET CAMBRIDGE MA 02142 0 1 0 0 SVP, General Counsel and Sec Stock Options 7.50 2017-12-27 4 A 0 150000 0.00 A 2024-12-27 Common Stock 150000 150000 D These Stock Options become exercisable in eight equal semi-annual installments beginning June 5, 2018. /s/ Colin Sandercock by Mark Busch, as attorney-in-fact 2017-12-27